Related Experiment Videos
Calcitonin in phantom limb pain.
1Adult Internal Medicine, Scott and White Hospital, Temple, TX, USA. geoffdoc@vvm.com
The Annals of Pharmacotherapy
|May 20, 1999
Summary
Salmon calcitonin may effectively treat phantom limb pain (PLP), a challenging condition. While generally safe, be aware of rare hypersensitivity reactions. Further research into intranasal calcitonin for PLP is recommended.
Area of Science:
- Pain Management
- Pharmacology
- Neurology
Background:
- Phantom limb pain (PLP) is a debilitating condition with limited treatment options.
- Effective and safe treatments for PLP are urgently needed to reduce patient morbidity.
Purpose of the Study:
- To evaluate the potential efficacy and safety of salmon calcitonin for treating phantom limb pain (PLP).
- To compare the effectiveness of intravenous and intranasal calcitonin formulations for pain relief.
Main Methods:
- Review of limited existing literature on salmon calcitonin use for PLP.
- Analysis of reported adverse effects, including hypersensitivity reactions.
- Comparison of efficacy between intravenous and intranasal calcitonin, particularly in related pain conditions.
Main Results:
- Intravenous salmon calcitonin (200 IU) may be effective with limited doses for PLP.
- Minor adverse effects are reported, suggesting relative safety, but severe hypersensitivity reactions are a risk.
- Intranasal calcitonin shows comparable efficacy to parenteral forms for certain pain types, e.g., vertebral crush fractures.
Conclusions:
- Salmon calcitonin presents a potential treatment option for phantom limb pain (PLP), despite limited evidence.
- Intranasal calcitonin offers a convenient administration route, warranting further investigation for long-term PLP relief.
- Clinicians must balance potential benefits against the risk of rare but severe hypersensitivity reactions.